AU676721B2 - Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof - Google Patents

Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof

Info

Publication number
AU676721B2
AU676721B2 AU61691/94A AU6169194A AU676721B2 AU 676721 B2 AU676721 B2 AU 676721B2 AU 61691/94 A AU61691/94 A AU 61691/94A AU 6169194 A AU6169194 A AU 6169194A AU 676721 B2 AU676721 B2 AU 676721B2
Authority
AU
Australia
Prior art keywords
ubiquitin
inhibitor
cleavage
mhc
atp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU61691/94A
Other languages
English (en)
Other versions
AU6169194A (en
Inventor
Alfred L. Goldberg
Kenneth L Rock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Dana Farber Cancer Institute Inc
Original Assignee
Harvard College
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Dana Farber Cancer Institute Inc filed Critical Harvard College
Publication of AU6169194A publication Critical patent/AU6169194A/en
Application granted granted Critical
Publication of AU676721B2 publication Critical patent/AU676721B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU61691/94A 1993-02-10 1994-01-27 Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof Ceased AU676721B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1606693A 1993-02-10 1993-02-10
US016066 1993-02-10
PCT/US1994/001183 WO1994017816A1 (fr) 1993-02-10 1994-01-27 Role de la proteolyse dependant de l'ubiquitine atp dans la presentation de l'antigene restreint chm-1 et inhibiteurs utilises a cet effet

Publications (2)

Publication Number Publication Date
AU6169194A AU6169194A (en) 1994-08-29
AU676721B2 true AU676721B2 (en) 1997-03-20

Family

ID=21775196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61691/94A Ceased AU676721B2 (en) 1993-02-10 1994-01-27 Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof

Country Status (5)

Country Link
EP (1) EP0684829A4 (fr)
JP (1) JPH08507754A (fr)
AU (1) AU676721B2 (fr)
CA (1) CA2155554A1 (fr)
WO (1) WO1994017816A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
US6287569B1 (en) 1997-04-10 2001-09-11 The Regents Of The University Of California Vaccines with enhanced intracellular processing
CA2219867A1 (fr) * 1997-10-31 1999-04-30 Jiangping Wu Utilisation d'inhibiteurs du proteasome dans le traitement du cancer, de l'inflammation, des maladies auto-immunes, du rejet de greffe et du choc septique
US5968747A (en) * 1997-12-12 1999-10-19 Incyte Pharmaceuticals, Inc. Ubiquitin-like conjugating protein
FR2779653B1 (fr) * 1998-06-11 2002-12-20 Inst Nat Sante Rech Med Utilisation de composes modulateurs du proteasome en therapie
NZ511197A (en) 1998-10-20 2003-08-29 Millenium Pharmaceuticals Inc Method for monitoring proteasome inhibitor drug action
JP2002105080A (ja) * 2000-09-29 2002-04-10 Microbial Chem Res Found 生理活性物質パネポフェナンスリンとその製造法
CA2532066C (fr) 2003-06-20 2015-07-28 Nereus Pharmaceuticals, Inc. Procedes d'utilisation de composes heterocycliques [3.2.0] et d'analogues de ces derniers
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
EP2516449A1 (fr) 2009-12-22 2012-10-31 Cephalon, Inc. Inhibiteurs du protéasome et leurs procédés de préparation, d'épuration et d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390629A (en) * 1981-03-30 1983-06-28 President And Fellows Of Harvard College Polypeptide degrading enzymes
US5340736A (en) * 1991-05-13 1994-08-23 The President & Fellows Of Harvard College ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting

Also Published As

Publication number Publication date
EP0684829A4 (fr) 1997-05-21
WO1994017816A1 (fr) 1994-08-18
JPH08507754A (ja) 1996-08-20
CA2155554A1 (fr) 1994-08-18
AU6169194A (en) 1994-08-29
EP0684829A1 (fr) 1995-12-06

Similar Documents

Publication Publication Date Title
Tan et al. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families
US5759994A (en) Recombinant thrombin receptor and related pharmaceuticals
AU676721B2 (en) Role of ATP-ubiquitin-dependent proteolysis in MHC-1 restricted antigen presentation and inhibitors thereof
CA2219964A1 (fr) Polypeptide capable de se lier a l'interleukine-18 et leurs utilisations
AU721194B2 (en) Thrombin receptor homolog
US7214772B2 (en) Sialoadhesin family member-2 (SAF-2)
US6451759B1 (en) Noncleavable Fas ligand
WO1998002579A1 (fr) Regulation de l'apoptose et modele in vitro destine a des recherches en la matiere
WO1997014797A9 (fr) Nouvel inhibiteur de cysteine proteinase, la cystatine m
WO1998002579A9 (fr) Regulation de l'apoptose et modele in vitro destine a des recherches en la matiere
AU732547B2 (en) Novel cyclin-selective ubiquitin carrier polypeptides
US6558900B2 (en) Regulation of apoptosis and in vitro model for studies thereof
EP0642354A1 (fr) PROCEDES PERMETTANT DE DETECTER ET D'ISOLER L'uPA-R ET D'INHIBER LA LIAISON DE L'uPA A L'uPA-R
US7176178B1 (en) Nuclear targeting by means of bacterial proteins
US6180379B1 (en) Cyclin-selective ubiquitin carrier polypeptides
US6833355B1 (en) Use of protein H as cytostatic agent
AU727222B2 (en) Regulation of apoptosis and in vitro model for studies thereof
WO2000023590A2 (fr) Inhibition d'activation de nfλb induite par cd40
MXPA97009746A (en) Homologo de receptor de tromb
JP2002523069A (ja) ＲＡＭＰ２ａ：受容体活性改変タンパク質‐２ａ
MXPA98008070A (en) Novedous polypeptides carriers of selected cybinetines of cicl